Solid Tumour Cancer Analysis

Clinical trials of over 70,000 patients have shown that personalised therapy, based on genomic profiling of tumours, is the most effective way to improve outcome, with higher response rates, longer progression free and overall survival, and fewer deaths related to toxic effects across all cancers.

Personalised therapy, based on genomic profiling of tumours, is the most effective way to improve outcomes.

Breakthrough Genomic (DNA) tests can solve the puzzle of your cancer as well as identifying targeted treatments or targeted clinical trials which may result in reduced side effects. Contact GRACE now!